Page last updated: 2024-08-16

temozolomide and lysine

temozolomide has been researched along with lysine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Balabanov, S; Bokemeyer, C; Braig, M; Hagel, C; Hauber, J; Lamszus, K; Pällmann, N; Preukschas, M; Schulte, A; Sievert, H; Weber, K1
Gallo, JM; Pickard, AJ; Wang, T1
Cai, J; Dinislam, M; Duan, C; Gao, F; Gao, W; Han, B; Jiang, C; Kang, C; Lin, L; Meng, X; Wang, R; Wu, P1
Alejo, S; Brenner, AJ; Chen, Y; Clarke, K; Gilbert, AR; He, Y; Jayamohan, S; Johnson, JD; Lai, Z; Li, W; Lv, Y; Palacios, BE; Pratap, UP; Sareddy, GR; Suzuki, T; Tekmal, RR; Vadlamudi, RK; Venkata, PP; Viswanadhapalli, S; Weldon, K; Ye, Z; Zhao, W; Zheng, S; Zou, Y1
Guimarães, DSPSF; Luchessi, AD; Pereira, KD; Silveira, LR; Tamborlin, L1
Fu, X; Li, J; Li, T; Shang, W; Wang, J; Wang, X; Zhang, L1
Gao, Z; Hu, R; Li, M; Li, Y; Liu, C; Mei, M; Pang, B; Ren, Y; Wang, Y; Yang, J; Zhang, B; Zhang, X; Zhou, X1

Other Studies

7 other study(ies) available for temozolomide and lysine

ArticleYear
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Apoptosis; Carmustine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Dacarbazine; Eukaryotic Translation Initiation Factor 5A; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Guanine; Humans; Lysine; Male; Mixed Function Oxygenases; Molecular Targeted Therapy; Neoplasm Grading; Oxidoreductases Acting on CH-NH Group Donors; Peptide Initiation Factors; RNA-Binding Proteins; Temozolomide

2012
Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug.
    Anticancer research, 2016, Volume: 36, Issue:7

    Topics: Animals; Antineoplastic Agents, Alkylating; Arginine; Dacarbazine; DNA Methylation; Histones; Humans; Lysine; Mass Spectrometry; Methylation; Temozolomide; Xenopus

2016
Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.
    Cancer letters, 2018, 04-10, Volume: 419

    Topics: Animals; Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; Brain Neoplasms; Cell Line, Tumor; Cell Survival; DNA Damage; DNA Repair; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Glioma; Histones; Humans; Lysine; Methylation; Mice, Nude; Temozolomide; X-linked Nuclear Protein; Xenograft Model Antitumor Assays

2018
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.
    Neuro-oncology, 2023, Jul-06, Volume: 25, Issue:7

    Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; DNA; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Histone Demethylases; Lysine; Mice; Tandem Mass Spectrometry; Temozolomide; Xenograft Model Antitumor Assays

2023
The first evidence of biological activity for free Hypusine, an enigmatic amino acid discovered in the '70s.
    Amino acids, 2023, Volume: 55, Issue:7

    Topics: Amino Acids; Animals; Cattle; Eukaryotic Translation Initiation Factor 5A; Lysine; Peptide Initiation Factors; Protein Processing, Post-Translational; Rats; Temozolomide

2023
Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
    Oncology research, 2023, Volume: 31, Issue:3

    Topics: Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Disease Models, Animal; Glioma; Humans; Hypoxia; Jumonji Domain-Containing Histone Demethylases; Lysine; Nuclear Proteins; Temozolomide

2023
Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma.
    Nature communications, 2023, 07-10, Volume: 14, Issue:1

    Topics: ErbB Receptors; Glioblastoma; Humans; Lysine; Methylation; NFATC Transcription Factors; Temozolomide; TNF Receptor-Associated Factor 6; Transcription Factors

2023